首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >New 6-amino-pyrido[2,3- d ]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α -glucosidase inhibition, molecular modeling and kinetic study
【24h】

New 6-amino-pyrido[2,3- d ]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α -glucosidase inhibition, molecular modeling and kinetic study

机译:新的6-氨基 - 吡啶[2,3- D]嘧啶-2,4-二酮作为一种治疗2型糖尿病的新药:简单有效的合成,α-葡糖苷酶抑制,分子模拟和动力学研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A new series of 6-amino-pyrido[2,3-d]pyrimidine-2,4-dione derivatives3a–3swere preparedviaa facile and efficient reaction fromα-azidochalcones and 6-amiouracils. The reactions were performed under mild conditions to produce the corresponding compounds in good to excellent yields. Obtained derivatives3a–3swere evaluated for α-glucosidase inhibitory activity and all of them exhibited excellentin?vitroyeastα-glucosidase inhibition with IC50values ranging from 78.0?±?2.0 to 252.4?±?1.0?μM. For example, the most active compound3owas around 10-fold more potent than acarbose, a standard drug (IC50?=?750.0?±?1.5?μM). Kinetic study of compound3orevealed that it inhibitedα-glucosidase in a competitive mode. Molecular modeling studies of the most active compounds3o,3i,3eand3mwere also performed.
机译:新系列6-氨基 - 吡啶[2,3-D]嘧啶-2,4-二酮衍生物3A-3spere制备viaa容易和高效的α-氮杂基和6- amiouracils反应。 在温和条件下进行反应,以优质的产率产生相应的化合物。 获得的衍生物3A-3S-3Sweer评估α-葡萄糖苷酶抑制活性,并且所有这些都表现出优异的蛋白α-葡糖苷酶抑制,其IC50值范围为78.0≤2.0至252.4?±1.0?μm。 例如,最活跃的化合物300as大约在10倍的高效比氨基糖,标准药物(IC50?=Δ750.0?±1.5?μm)。 化合物的动力学研究耐血液抑制α-葡糖苷酶在竞争模式中。 分子建模研究最活跃的化合物3O,3I,3.3MWERE也进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号